Literature DB >> 21232967

The GeoForm annuloplasty ring for the surgical treatment of functional mitral regurgitation in advanced dilated cardiomyopathy.

Michele De Bonis1, Maurizio Taramasso, Antonio Grimaldi, Francesco Maisano, Maria Chiara Calabrese, Alessandro Verzini, David Ferrara, Ottavio Alfieri.   

Abstract

OBJECTIVE: To assess the results of the three-dimensional (3D)-shaped GeoForm ring for the treatment of functional mitral regurgitation (FMR).
METHODS: Seventy-four patients with severe FMR and systolic dysfunction underwent GeoForm ring implantation. Forty-six patients (62%) were in the New York Heart Association (NYHA) class III-IV. Concomitant procedures were coronary artery bypass grafting (CABG) (33 patients (pts)), tricuspid repair (23 pts), atrial fibrillation ablation (20 pts), aortic valve replacement (eight pts) and left-ventricular (LV) reconstruction (five pts).
RESULTS: Hospital mortality was 9%. Three more patients died after hospital discharge. Overall survival was 81.1 ± 6.6% at 3.5 years. The 67 hospital survivors underwent clinical and echocardiographic follow-up at a mean follow-up period of 1.9 ± 1.25 years (median 1.7 years). MR was absent or mild in 83% of the patients (56/67), moderate in 7% (5/67), and moderate to severe in the remaining 9% (6/67). At 3.5 years, overall freedom from MR ≥ 3+ was 85.1 ± 8% and freedom from MR ≥ 2+ was 75.1 ± 8.6%. Statistical analysis identified preoperative asymmetric tethering with prevalent restricted motion of the posterior leaflet as the only predictor of recurrence of MR ≥ 2+ (hazard ratio (HR) 6.1, p=0.005). Reverse LV remodeling was demonstrated in 31 of the 54 patients eligible for this specific analysis (31/54, 57%): Both LV end-diastolic and end-systolic volumes indexed significantly decreased (both p=0.0001) as well as systolic pulmonary artery pressure (SPAP) (p=0.006). Ejection fraction increased from 33 ± 8% to 43 ± 8% (p<0.0001). Stress echocardiography was performed in a subgroup of eight patients. Mean mitral area at rest was 2.2 ± 0.3 cm² and did not change during stress. Cardiac output significantly increased in all patients during exercise. Although mean and peak transmitral gradients were 3.3 ± 1.3 and 8.1 ± 2.2 mmHg at rest and 6.6 ± 2.5 and 14.8 ± 3.9 mmHg under stress, respectively (both p<0.003), the increase in SPAP was not statistically significant (28 ± 3.0 vs 31 ± 7.5 mm Hg, p=0.17), revealing a preserved cardiac adaptation to exercise.
CONCLUSIONS: The GeoForm ring is effective in relieving FMR in most of the patients with dilated cardiomyopathy. In presence of prevalent restricted motion of the posterior leaflet, recurrence of significant MR is more likely to occur. Clinically relevant mitral stenosis was not detected during exercise.
Copyright © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21232967     DOI: 10.1016/j.ejcts.2010.11.048

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  13 in total

Review 1.  MitraClip-data analysis of contemporary literature.

Authors:  Florian Deuschl; Niklas Schofer; Edith Lubos; Johannes Schirmer; Lenard Conradi; Hendrik Treede; Hermann Reichenspurner; Stefan Blankenberg; Ulrich Schäfer
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

2.  Implantation of personalized, biocompatible mitral annuloplasty rings: feasibility study in an animal model.

Authors:  Simon H Sündermann; Michael Gessat; Nikola Cesarovic; Thomas Frauenfelder; Patric Biaggi; Dominique Bettex; Volkmar Falk; Stephan Jacobs
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-03

3.  Measurement of mitral leaflet and annular geometry and stress after repair of posterior leaflet prolapse: virtual repair using a patient-specific finite element simulation.

Authors:  Liang Ge; William G Morrel; Alison Ward; Rakesh Mishra; Zhihong Zhang; Julius M Guccione; Eugene A Grossi; Mark B Ratcliffe
Journal:  Ann Thorac Surg       Date:  2014-03-13       Impact factor: 4.330

4.  Mitral valve annuloplasty: a quantitative clinical and mechanical comparison of different annuloplasty devices.

Authors:  Manuel K Rausch; Wolfgang Bothe; John-Peder Escobar Kvitting; Julia C Swanson; D Craig Miller; Ellen Kuhl
Journal:  Ann Biomed Eng       Date:  2011-10-25       Impact factor: 3.934

Review 5.  Functional mitral regurgitation: a 30-year unresolved surgical journey from valve replacement to complex valve repairs.

Authors:  Francesco Onorati; Francesco Santini; Rajesh Dandale; Andrea Rossi; Esther Campopiano; Konstantinos Pechlivanidis; Daniele Calzaferri; Aldo Milano; Alessandro Mazzucco; Giuseppe Faggian
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

6.  Computational virtual evaluation of the effect of annuloplasty ring shape.

Authors:  Ahnryul Choi; David D McPherson; Hyunggun Kim
Journal:  Int J Numer Method Biomed Eng       Date:  2016-10-05       Impact factor: 2.747

7.  How do annuloplasty rings affect mitral annular strains in the normal beating ovine heart?

Authors:  Wolfgang Bothe; Manuel K Rausch; John-Peder Escobar Kvitting; Dominique K Echtner; Mario Walther; Neil B Ingels; Ellen Kuhl; D Craig Miller
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

8.  Interventional vs. surgical mitral valve therapy. Which technique for which patient?

Authors:  M Taramasso; N Buzzatti; G La Canna; A Colombo; O Alfieri; F Maisano
Journal:  Herz       Date:  2013-08       Impact factor: 1.443

9.  Long-term outcomes of etiology specific annuloplasty ring repair of ischemic mitral regurgitation.

Authors:  Tomasz A Timek; Marcin Malinowski; Robert L Hooker; Jessica L Parker; Charles L Willekes; Edward T Murphy; Theodore Boeve; Stephane Leung; Justin S Fanning; John C Heiser
Journal:  Ann Cardiothorac Surg       Date:  2021-01

Review 10.  Ischemic Mitral Regurgitation: A Multifaceted Syndrome with Evolving Therapies.

Authors:  Mattia Vinciguerra; Francesco Grigioni; Silvia Romiti; Giovanni Benfari; David Rose; Cristiano Spadaccio; Sara Cimino; Antonio De Bellis; Ernesto Greco
Journal:  Biomedicines       Date:  2021-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.